BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1688 related articles for article (PubMed ID: 29498630)

  • 1. Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids.
    Lee HJ; Jang YJ
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29498630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular basis of keloid and hypertrophic scar formation.
    Tuan TL; Nichter LS
    Mol Med Today; 1998 Jan; 4(1):19-24. PubMed ID: 9494966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keloids and Hypertrophic Scars Can Now Be Cured Completely: Recent Progress in Our Understanding of the Pathogenesis of Keloids and Hypertrophic Scars and the Most Promising Current Therapeutic Strategy.
    Ogawa R; Akaishi S; Kuribayashi S; Miyashita T
    J Nippon Med Sch; 2016; 83(2):46-53. PubMed ID: 27180789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of Silicone Gel Sheeting and Silicone Gel for the Prevention of Hypertrophic Scars and Keloids.
    Hsu KC; Luan CW; Tsai YW
    Wounds; 2017 May; 29(5):154-158. PubMed ID: 28570253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and management of hypertrophic scars and keloids after burns in children.
    Berman B; Viera MH; Amini S; Huo R; Jones IS
    J Craniofac Surg; 2008 Jul; 19(4):989-1006. PubMed ID: 18650721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic scars and keloids.
    Haverstock BD
    Clin Podiatr Med Surg; 2001 Jan; 18(1):147-59. PubMed ID: 11344975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy.
    Tredget EE; Nedelec B; Scott PG; Ghahary A
    Surg Clin North Am; 1997 Jun; 77(3):701-30. PubMed ID: 9194888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenesis of hypertrophic/keloid scarring.
    Thomas DW; Hopkinson I; Harding KG; Shepherd JP
    Int J Oral Maxillofac Surg; 1994 Aug; 23(4):232-6. PubMed ID: 7798696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperplastic scars and keloids. Part I: basics and prevention].
    Baisch A; Riedel F
    HNO; 2006 Nov; 54(11):893-904; quiz 905. PubMed ID: 17041777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
    Ogawa R; Akaishi S
    Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
    Ogawa R
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management.
    Slemp AE; Kirschner RE
    Curr Opin Pediatr; 2006 Aug; 18(4):396-402. PubMed ID: 16914994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Most Current Algorithms for the Treatment and Prevention of Hypertrophic Scars and Keloids: A 2020 Update of the Algorithms Published 10 Years Ago.
    Ogawa R
    Plast Reconstr Surg; 2022 Jan; 149(1):79e-94e. PubMed ID: 34813576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in scar management: prevention and management of hypertrophic scars and keloids.
    Del Toro D; Dedhia R; Tollefson TT
    Curr Opin Otolaryngol Head Neck Surg; 2016 Aug; 24(4):322-9. PubMed ID: 27163611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies.
    Gauglitz GG; Korting HC; Pavicic T; Ruzicka T; Jeschke MG
    Mol Med; 2011; 17(1-2):113-25. PubMed ID: 20927486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Latest Strategy for Keloid and Hypertrophic Scar Prevention and Treatment: The Nippon Medical School (NMS) Protocol.
    Ogawa R; Dohi T; Tosa M; Aoki M; Akaishi S
    J Nippon Med Sch; 2021 Mar; 88(1):2-9. PubMed ID: 32741903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
    Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
    J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment.
    Berman B; Maderal A; Raphael B
    Dermatol Surg; 2017 Jan; 43 Suppl 1():S3-S18. PubMed ID: 27347634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of keloids and hypertrophic scars.
    Juckett G; Hartman-Adams H
    Am Fam Physician; 2009 Aug; 80(3):253-60. PubMed ID: 19621835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Keloid scars (part II): Treatment and prevention].
    Jaloux C; Bertrand B; Degardin N; Casanova D; Kerfant N; Philandrianos C
    Ann Chir Plast Esthet; 2017 Feb; 62(1):87-96. PubMed ID: 27209565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 85.